BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 19952801)

  • 1. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey.
    Morgensztern D; Ng SH; Gao F; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):29-33. PubMed ID: 19952801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
    Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Govindan R
    J Thorac Oncol; 2008 Feb; 3(2):135-9. PubMed ID: 18303433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
    Geiger GA; Kim MB; Xanthopoulos EP; Pryma DA; Grover S; Plastaras JP; Langer CJ; Simone CB; Rengan R
    Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
    Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
    Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.
    Gauger J; Patz EF; Coleman RE; Herndon JE
    J Thorac Oncol; 2007 Jun; 2(6):499-505. PubMed ID: 17545844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI.
    Tang W; Wu N; OuYang H; Huang Y; Liu L; Li M
    Cancer Imaging; 2015 Sep; 15(1):14. PubMed ID: 26335333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of computed tomography morphologic characteristics in stage I non-small-cell lung cancer.
    Meniga IN; Tiljak MK; Ivankovic D; Aleric I; Zekan M; Hrabac P; Mazuranic I; Puljic I
    Clin Lung Cancer; 2010 Mar; 11(2):98-104. PubMed ID: 20199975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
    Bryant AS; Cerfolio RJ
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
    Hanna GG; McAleese J; Carson KJ; Stewart DP; Cosgrove VP; Eakin RL; Zatari A; Lynch T; Jarritt PH; Young VA; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):24-30. PubMed ID: 19665324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.
    Nakajima T; Yasufuku K; Nakajima M; Baba M; Yoshikawa K; Kamada T; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    J Thorac Oncol; 2010 May; 5(5):606-11. PubMed ID: 20354458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer.
    Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological correlates of the maximum 18-fluoro-2-deoxy-glucose uptake on positron emission tomography in non-small cell lung carcinoma after induction chemotherapy.
    Dooms C; Verbeken E; Stroobants S; Vansteenkiste J
    J Thorac Oncol; 2009 Oct; 4(10):1221-5. PubMed ID: 19641474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
    Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
    J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Gould MK; Schultz EM; Wagner TH; Xu X; Ghaus SJ; Wallace RB; Provenzale D; Au DH
    J Thorac Oncol; 2011 May; 6(5):875-83. PubMed ID: 21572580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Govindan R
    J Thorac Oncol; 2009 Dec; 4(12):1524-9. PubMed ID: 19752759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
    Duan Y; Yu LJ; Lu PO; Wang WZ
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
    Nakamura H; Hirata T; Kitamura H; Nishikawa J
    Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics.
    Kishi K; Homma S; Kurosaki A; Motoi N; Kohno T; Nakata K; Yoshimura K
    Lung Cancer; 2004 Apr; 44(1):43-51. PubMed ID: 15013582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
    Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
    Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.